Christos Fountzilas, Andrew H. Ko, Erkut Hasan Borazanci, James Thomas D'Olimpio, J. Randolph Hecht, Shou-Ching Tang, Anthony F. Shields, Mohamad Adham Salkeni, Glenn Michelson, Gene Cho, Lorna Liganor, Sangsook Ahn Cho, Evan Justin Walker. A randomized, multi-center, phase 2 study of ivaltinostat (Ival) plus capecitabine (Cape) versus capecitabine alone in the maintenance setting in patients with metastatic pancreatic adenocarcinoma (mPDAC). Journal of Clinical Oncology. 2024 May 29; 42(16_suppl):tps4206-tps4206.